My main takeaway here is that they were able to make the Flucide more effective! So, since they seem to have figured out the "tweaking" formula, they very well might be able to make the Denguecide more effective, as well as their other viricide candidates. The market would probably react better if the results were from a lab other than Menon's, but that will come in time. Yes, this certainly should be seen as a giant step towards being able to meet with the FDA,IMO. This may yet be a good year for the stock price.
Lee